Article
Hyper-Glycosylation as a Central Metabolic Driver of Alzheimer’s Disease
2025-05-05
Abstract excerpt
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by devastating degenerative decline. Metabolic disruptions are widely observed, yet their involvement in the molecular etiology of AD remains underexplored. Utilizing spatial metabolomics, lipidomics, and glycomics in both mouse models and human post-mortem samples, we identified a hyper-glycosylation phenotype as a hallmark of AD. To investiga...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7dc03130-dc5a-58df-805d-bd47e443a0a2
- DOI
- 10.1101/2025.04.30.651461
